Global University Venturing

The Oxford-backed corporate education resource provider’s overall funding now stands at more than $280m.

Several corporates helped the Montana State University-backed microbial protein developer take its total funding above $500m.

The UChicago-backed digital home insurance provider is joining forces with Omnichannel Acquisition Corp at a valuation of just over $1bn.

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.

WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.

The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.

Patient Square Capital has led a series B round for the Stanford-linked gene therapy developer, which previously collected $80.5m in May last year.

The IGBMC spinout was set up by Satt Conectus and is now seeking a listing in the US with a price range of $15 to $17.

MIT’s battery technology spinout will collect $200m in a private investment in public equity financing and list on the New York Stock Exchange.

IP Group has returned for a series C round for the PNNL spinout, having already backed the series A and B rounds.